Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00693160 · ClinicalTrials.gov registry record · Phase 2
Effect of Spinal Ketorolac After Acute Opioid Exposure
A Phase 2 study, sponsored by Wake Forest University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT00693160 is a Phase 2 study that was terminated before completion, run by Wake Forest University. The registered enrollment target is 30 participants.
The verdict
NCT00693160, a Phase 2 study, was terminated before completion, sponsored by Wake Forest University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
This research study is being done because pain is a significant problem for patients with a variety of medical problems and following surgery or traumatic injury. Currently available pain medications may not treat all types of pain or may treat pain only at doses that produce side effects and complications. The medication in this study may have a role in better treatment of pain. The goals of this study are to see if a dose of ketorolac (non-narcotic, pain reliever), given into the fluid in the back near the spine has any effect on pain or discomfort in the skin sensation that will take place after applying capsaicin (chili pepper) cream. The sunburn-like sensation that people experience after having capsaicin cream applied is similar to, but much milder than, the pain that some people have after surgery and after certain types of nerve injuries. This study will test the effects of combining two medications that are often given together to control postoperative pain or pain from a nerve injury. The investigators are especially interested in answering two questions about the effects of ketorolac (non-narcotic pain reliever) and remifentanil (intravenous \[IV\] narcotic painkiller): 1. How much does remifentanil (narcotic painkiller) affect the sunburn-like painful area on your skin, which develops after applying capsaicin cream? 2. What pain relieving effects does spinal ketorolac have when given with IV remifentanil?
Interventions
- DRUG placebo
- DRUG ketorolac
- DRUG Capsaicin
- DRUG remifentanil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-12 |
| Est. Completion | 2011-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00693160
The ClinicalTrials.gov registry entry for NCT00693160 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which placebo is the first listed.
NCT00693160 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00693160 about?
NCT00693160 is a clinical study titled "Effect of Spinal Ketorolac After Acute Opioid Exposure". This research study is being done because pain is a significant problem for patients with a variety of medical problems and following surgery or traumatic injury. Currently available pain medications may not treat all types of pain or may treat pain only at doses that produce side effects and compli...
What is the current status of trial NCT00693160?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2007-12. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00693160?
The interventions under investigation include: placebo (DRUG), ketorolac (DRUG), Capsaicin (DRUG), remifentanil (DRUG).
Who is sponsoring clinical trial NCT00693160?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.